Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Director · President, CEO | August 11, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date August 11, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,201,814 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 28,800 · Balance 1,201,814 F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 26,862 | $4.80 | $128,937.60 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 758,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| November 21, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 59,150 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · derivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,862 Underlying: Common Stock · 59,150 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| November 21, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 50,000 | $6.51 | $325,275.00 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 731,897 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.66, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 59,150 | $4.80 | $283,920.00 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 781,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 9 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,012 Underlying: Common Stock · 60,000 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 50,000 | $6.65 | $332,295.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 722,747 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.93, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 60,000 | $4.80 | $288,000.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 772,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 60,440 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,012 Underlying: Common Stock · 60,440 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 50,000 | $6.78 | $338,985.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 712,747 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.48 to $6.935, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 60,440 | $4.80 | $290,112.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 762,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| November 18, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 60,215 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · derivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,452 Underlying: Common Stock · 60,215 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| November 18, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 50,000 | $6.73 | $336,540.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,307 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.94, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 21, 2024 00:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 60,215 | $4.80 | $289,032.00 |
DisclosureSEC source: 0001104659-24-121156 · tm2429078-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 00:09 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,631 | $17.54 | $46,153.79 |
DisclosureSEC source: 0001104659-24-039194 · tm249900-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,182 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 33,524 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · derivative · entry 9 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,524 Underlying: Common Stock · 33,524 shares Expires 2031-03-15 F7 · derivative.exercise_date: 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · derivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 100,000 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 54,440 | $15.04 | $818,853.82 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,813 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.84 to $15.28, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 100,000 | $4.80 | $480,000.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 14,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649,253 F3 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. F3 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,599 | $20.79 | $54,030.61 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,352 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 11, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,723 | $16.35 | $60,879.99 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 636,951 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · derivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,250 Underlying: Common Stock · 8,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F5 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. F5 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 19, 2024 23:48 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036281 · tm249281-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 54,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,007 Underlying: Common Stock · 54,000 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 26,875 | $14.27 | $383,406.81 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632,424 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.09 to $14.36, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 54,000 | $1.87 | $100,980.00 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 659,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 286,377 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 286,377 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested over four years in 48 equal installments beginning 7/28/2013. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 141,159 | $21.63 | $3,053,509.14 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,299 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $21.92, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 286,377 | $3.24 | $927,861.48 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 746,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 60,952 | $0.00 Strike: $23.78 | $0.00 |
DisclosureSEC source: 0001104659-23-036713 · tm2310574-2_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,952 Underlying: Common Stock · 60,952 shares Expires 2030-03-22 F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 27,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-036713 · tm2310574-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,081 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,599 | $20.79 | $54,033.21 |
DisclosureSEC source: 0001104659-23-033870 · tm239899-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,989 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 01:23 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,798 | $20.14 | $76,491.72 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,588 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:23 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 8,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:23 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 60,952 | $0.00 Strike: $29.69 | $0.00 |
DisclosureSEC source: 0001104659-22-034628 · tm229493-3_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,952 Underlying: Common Stock · 60,952 shares Expires 2029-03-14 F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 27,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-034628 · tm229493-3_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,136 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 8,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,298 | $31.05 | $102,402.90 |
DisclosureSEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,044 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| December 28, 2021 Filed Feb 15, 2022 23:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GiftCommon Stock | 165,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023895 · tm225040-2_5.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,092 Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 287 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 14 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,377 Underlying: Common Stock · 287 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F11 · derivative.exercise_date: 1/24 of the options vested immediately and 1/46 of the remaining options vested on the 5th of each month for forty six months beginning on 7/5/2013 and ending on 5/5/2017. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 87 | $65.84 | $5,728.08 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 11 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,092 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 200 | $64.87 | $12,973.00 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 10 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,179 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.18, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 287 | $3.24 | $929.88 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 9 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 38,545 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 13 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,664 Underlying: Common Stock · 38,545 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F10 · derivative.exercise_date: 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 26,418 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 12 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,418 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F9 · derivative.exercise_date: 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,309 | $66.87 | $87,532.57 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,092 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.6950, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 8,092 | $65.54 | $530,330.26 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,401 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 13:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 29,144 | $64.89 | $1,891,040.50 |
DisclosureSEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,493 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.